polyclonal antibodies against adipor1 Search Results


rabbit polyclonal primary antibody against adipor1  (Abbiotec Inc)
90
Abbiotec Inc rabbit polyclonal primary antibody against adipor1
The mRNA levels of <t> adiponectin receptors </t> in tissues extracted from patients with RCC who underwent renal surgery.
Rabbit Polyclonal Primary Antibody Against Adipor1, supplied by Abbiotec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal primary antibody against adipor1/product/Abbiotec Inc
Average 90 stars, based on 1 article reviews
rabbit polyclonal primary antibody against adipor1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


The mRNA levels of adiponectin receptors in tissues extracted from patients with RCC who underwent renal surgery.

Journal: PLoS ONE

Article Title: The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”

doi: 10.1371/journal.pone.0171615

Figure Lengend Snippet: The mRNA levels of adiponectin receptors in tissues extracted from patients with RCC who underwent renal surgery.

Article Snippet: The tissues were incubated with a rabbit polyclonal primary antibody against AdipoR1 (Abbiotec, San Diego, CA) diluted 1:200.

Techniques: Expressing

An immunoreactivity score > 4 was defined as high AdipoR1 levels, and an immunoreactivity score ≤4 was defined as low AdipoR1 levels. A Representative images of low and high AdipoR1 levels in human RCC epithelial tissue. AdipoR1 immunoreactivity score was not significantly associated with CSS in the overall RCC patient population (B) and in patients with non-metastatic RCC (C).

Journal: PLoS ONE

Article Title: The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”

doi: 10.1371/journal.pone.0171615

Figure Lengend Snippet: An immunoreactivity score > 4 was defined as high AdipoR1 levels, and an immunoreactivity score ≤4 was defined as low AdipoR1 levels. A Representative images of low and high AdipoR1 levels in human RCC epithelial tissue. AdipoR1 immunoreactivity score was not significantly associated with CSS in the overall RCC patient population (B) and in patients with non-metastatic RCC (C).

Article Snippet: The tissues were incubated with a rabbit polyclonal primary antibody against AdipoR1 (Abbiotec, San Diego, CA) diluted 1:200.

Techniques:

The relationship between AdipoR1 expression and clinicopathological outcomes by immunohistochemistry.

Journal: PLoS ONE

Article Title: The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”

doi: 10.1371/journal.pone.0171615

Figure Lengend Snippet: The relationship between AdipoR1 expression and clinicopathological outcomes by immunohistochemistry.

Article Snippet: The tissues were incubated with a rabbit polyclonal primary antibody against AdipoR1 (Abbiotec, San Diego, CA) diluted 1:200.

Techniques: Expressing, Immunohistochemistry

A. Adiponectin receptor 1 (AdipoR1) (upper) and β-actin (lower) protein levels in Caki-1, Caki-2, 786-O, ACHN, and RENCA cells were determined using western blot. AdipoR1 was detected in all cell lines. B. Caki-2 and 786-O cells were treated with various concentrations of recombinant adiponectin (Ad) (25–1000 ng/mL) and analyzed using an MTT assay 0, 24, and 48 h after adiponectin stimulation. *p < 0.05 compared with cell viability at 0 h. C. The histogram presents the invasive capacity of Caki-2 and 786-O cells treated with 250 or 1000 ng/ml recombinant adiponectin. The number of invasive cells in adiponectin-treated cells was compared with the number of invasive cells at 0 h (untreated cells). D. Caki-2 and 786-O cells were stimulated with 250–1000 ng/ml recombinant adiponectin. Cell migration to the wound surface was analyzed under a light microscope. The diameter of the wound in Caki-2 and 786-O cells treated with various concentration of recombinant adiponectin for 24 h was compared with the diameter of the wound in untreated cells.

Journal: PLoS ONE

Article Title: The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”

doi: 10.1371/journal.pone.0171615

Figure Lengend Snippet: A. Adiponectin receptor 1 (AdipoR1) (upper) and β-actin (lower) protein levels in Caki-1, Caki-2, 786-O, ACHN, and RENCA cells were determined using western blot. AdipoR1 was detected in all cell lines. B. Caki-2 and 786-O cells were treated with various concentrations of recombinant adiponectin (Ad) (25–1000 ng/mL) and analyzed using an MTT assay 0, 24, and 48 h after adiponectin stimulation. *p < 0.05 compared with cell viability at 0 h. C. The histogram presents the invasive capacity of Caki-2 and 786-O cells treated with 250 or 1000 ng/ml recombinant adiponectin. The number of invasive cells in adiponectin-treated cells was compared with the number of invasive cells at 0 h (untreated cells). D. Caki-2 and 786-O cells were stimulated with 250–1000 ng/ml recombinant adiponectin. Cell migration to the wound surface was analyzed under a light microscope. The diameter of the wound in Caki-2 and 786-O cells treated with various concentration of recombinant adiponectin for 24 h was compared with the diameter of the wound in untreated cells.

Article Snippet: The tissues were incubated with a rabbit polyclonal primary antibody against AdipoR1 (Abbiotec, San Diego, CA) diluted 1:200.

Techniques: Western Blot, Recombinant, MTT Assay, Migration, Light Microscopy, Concentration Assay